Why is Soni Medicare falling/rising?

As of 15-Jul, Soni Medicare Ltd's stock price is currently at 58.03, reflecting an increase of 1.13 or 1.99%. The stock has shown strong performance over the past month with a return of 16.06%, significantly outperforming the Sensex, which only gained 1.79%. Despite a recent decline in investor participation, as evidenced by a 62.02% drop in delivery volume compared to the 5-day average, the stock remains liquid enough for trading. The company's attractive valuation, with a return on capital employed (ROCE) of 7.7 and a favorable enterprise value to capital employed ratio of 3.4, supports its recent price increase. However, the high debt levels, indicated by a debt-equity ratio of 6.6 times and a debt to EBITDA ratio of 4.34 times, raise concerns about long-term fundamental strength, which could impact investor sentiment.
In the broader market context, Soni Medicare's stock has outperformed the benchmark significantly over the past year, generating a return of 118.98% compared to the BSE500's 0.37%. This strong performance is indicative of the company's ability to deliver returns that exceed market expectations, despite the challenges posed by its high debt levels and reported losses. The stock's recent upward movement can be attributed to its solid performance metrics and attractive valuation relative to peers, even as the overall market has faced some headwinds.